GlycoNet researchers have made exciting advances in understanding Alzheimer’s disease and are developing a potential therapeutic strategy.
Category: Research Highlight
Enzymes in bacteria found to have an unexpected taste for carbs
GlycoNet researchers studying complex enzymes gain insight into how some pathogens could potentially be targeted without antibiotics.
SARS-CoV-2 uses sugars to invade human cells, new study shows
Understanding the process could help scientists look out for new, more infectious variants, say GlycoNet researchers.
New anti-diabetic treatment approved for human trials
A natural compound that slows the breakdown of starch could be used to develop a more pleasant treatment for managing Type 2 diabetes.
Innovative coating for blood vessels reduces rejection of transplanted organs
Knowledge in the sugars that coat blood vessels helps researchers find a way to reduce organ rejection.
Solving blood supply shortage with glycomics
GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood
Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
GlycoNet researchers discover how a plaque-fighting protein protects against Alzheimer’s
Research highlights potential pathway for new treatments for neurodegenerative diseases
Tackling the root cause of neurodegenerative disease
Professor and GlycoNet Investigator Simonetta Sipione’s research awarded major grant from the Canadian Institutes of Health Research
New radiotracers could be key for new treatments and early detection for Parkinson’s
Nuclear medicine researcher and GlycoNet Investigator Chris Phenix from the University of Saskatchewan has been awarded US$150,000 by The Michael J. Fox Foundation to develop diagnostic radiotracers for early detection of Parkinson’s Disease
English 
French